Guinevere Lageveen-Kammeijer coordinates European Partnership for Personalised Medicine
Guinevere Lageveen-Kammeijer and Peter Horvatovich, alongside their partners at Treat4Life (Sweden), Helmholtz Munich (Germany), HCEM (Hungary), Turbine (Hungary), and Lund University (Sweden), have been awarded a prestigious European Partnership for Personalised Medicine (EP PerMed) from the European Commission. This 3-year project will focus on utilizing AI and large-scale biobanking to validate drug targets and biomarkers for personalized melanoma treatment (PerMel-AI). Guinevere is the coordinator of the PerMel-AI project, with a total funding of €1.3 million – of which €250k is awarded to the Analytical Biochemistry research group (subsidized by ZonMW).
| Last modified: | 09 May 2025 12.24 p.m. |
More news
-
06 June 2025
India-Netherlands Hydrogen Valley Fellowship Programme announced
To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.